KIAA1328 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.28569999991291E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.37649999573964E-08 |
Normal-vs-Stage2 |
5.6744999998859E-07 |
Normal-vs-Stage3 |
3.24940000462348E-08 |
Normal-vs-Stage4 |
3.06500000046839E-07 |
Stage1-vs-Stage2 |
5.048600E-01 |
Stage1-vs-Stage3 |
8.034300E-02 |
Stage1-vs-Stage4 |
1.198960E-01 |
Stage2-vs-Stage3 |
2.712200E-01 |
Stage2-vs-Stage4 |
9.286100E-02 |
Stage3-vs-Stage4 |
6.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.1296000002623E-07 |
Normal-vs-AfricanAmerican |
1.48219999995813E-06 |
Normal-vs-Asian |
8.13970000000941E-05 |
Caucasian-vs-AfricanAmerican |
8.072800E-01 |
Caucasian-vs-Asian |
9.351600E-02 |
AfricanAmerican-vs-Asian |
2.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.33260000204183E-08 |
Normal-vs-Female |
8.29159999999884E-05 |
Male-vs-Female |
1.332220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.56865999999534E-05 |
Normal-vs-Extreme_Weight |
1.413500E-04 |
Normal-vs-Obese |
2.97829999995614E-07 |
Normal-vs-Extreme_Obese |
5.84009999999857E-05 |
Normal_Weight-vs-Extreme_Weight |
9.911400E-01 |
Normal_Weight-vs-Obese |
9.691800E-01 |
Normal_Weight-vs-Extreme_Obese |
6.284000E-01 |
Extreme_Weight-vs-Obese |
9.855600E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.710600E-01 |
Obese-vs-Extreme_Obese |
5.285400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.57852000000069E-05 |
Normal-vs-Age(41-60Yrs) |
6.7126000002915E-07 |
Normal-vs-Age(61-80Yrs) |
8.80340000009028E-07 |
Normal-vs-Age(81-100Yrs) |
2.11289999999531E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.295600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.788800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.486400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.811000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.361200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.308400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
5.5366999995865E-07 |
Normal-VS-Type2 PRCC |
2.30404584300459E-12 |
Normal-VS-KIRP CIMP |
3.67580000004697E-06 |
Normal-VS-Unclassified PRCC |
1.375320E-03 |
Type1 PRCC-VS-Type2 PRCC |
4.099400E-03 |
Type1 PRCC-VS-KIRP CIMP |
2.021400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.895600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.291800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.227600E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.114630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.68089994648335E-10 |
Normal-vs-N1 |
5.29449994957076E-09 |
Normal-vs-N2 |
8.588500E-04 |
N0-vs-N1 |
6.097600E-01 |
N0-vs-N2 |
5.775400E-01 |
N1-vs-N2 |
7.213400E-01 |
|
|